Eur J Clin Pharmacol. 1977 Jan 03;11(2):75-8. doi: 10.1007/BF00562895.

The ambiguity of adverse drug reactions.

European journal of clinical pharmacology

J Koch-Weser, E M Sellers, R Zacest

PMID: 837969 DOI: 10.1007/BF00562895

Abstract

Three clinical pharmacologists independently evaluated 500 untoward clinical events reported by physicians as adverse drug reactions (ADRs). They often disagreed with the reporting physicians and with each other. They judged 14.4-28.2% of the events to be definite, 26.4-38.0% probable, 21.4-31.0% possible and 15.8-28.2% of the events to be definite, 26.4-38.0% probable, 21.4-31.0% possible and 15.8-28.2% unlikely ADRs. In their opinion 19.1-32.4% of the drugs blamed were definitely, 29.8-34.4% probably, 24.9-36.7% possibly and 8.4-14.5% not responsible for the adverse reactions. Evaluators disagreed among themselves about the drug most likely to have been responsible in 36.4% of the events, about ADRs causing hospital admission in 56.8%, about severe ADR morbidity in 55.8%, about ADR prolongation of hospitalization in 67.3% and ADR prolongation of hospitalization in 67.3% and about ADR contribution to death in 71.0%. The divergence of judgements suggests that suspected ADRs are usually ambiguous clinical events, and that incidence, severity, medical consequences and cost of ADRs can only be estimated.

Similar articles

Cited by

References

1. JAMA. 1976 Aug 9;236(6):575-8 - PubMed
2. JAMA. 1975 Dec 22;234(12):1236-41 - PubMed
3. N Engl J Med. 1969 Jan 2;280(1):20-6 - PubMed
4. Clin Pharmacol Ther. 1974 Jul;16(1):110-23 - PubMed
5. N Engl J Med. 1968 Sep 26;279(13):678-9 - PubMed
6. Ann Intern Med. 1964 Feb;60:255-65 - PubMed
7. Clin Pharmacol Ther. 1976 May;19(5 Pt 1):489-92 - PubMed
8. N Engl J Med. 1974 Aug 8;291(6):302-3 - PubMed

MeSH terms

• Drug-Related Side Effects and Adverse Reactions*
• Evaluation Studies as Topic
• Hospitals
• Humans

Publication Types

• Journal Article

LinkOut - more resources

• Full Text Sources
  • Springer